Skip to main content

Together we are beating cancer

Donate now

Breast cancer

Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.
Showing 12 out of 632 results
An electron microscopy image of a breast cancer cell

Results from our clinical trial show a drug called anastrozole can halve the chance of developing breast cancer in some women. We explore the findings. Results from our clinical trial show a drug called anastrozole can halve the chance of developing breast cancer in some women. We explore the findings.

by Nikki Smith | Analysis | 12 December 2013

12 December 2013

Young black women in the UK diagnosed with breast cancer aged 40 or younger have poorer overall survival than white women in the same age group. Young black women in the UK diagnosed with breast cancer aged 40 or younger have poorer overall survival than white women in the same age group.

by Cancer Research UK | News | 23 October 2013

23 October 2013

Cancer Research UK scientists have found a way of delivering drugs more effectively to treat life-threatening cancers that have spread to the brain. Cancer Research UK scientists have found a way of delivering drugs more effectively to treat life-threatening cancers that have spread to the brain.

by Cancer Research UK | News | 9 October 2013

9 October 2013

Cancer Research UK logo

Continuing Our Milestones series, we take a look at a key breast cancer molecule and the development of the breast cancer drug Herceptin. Continuing Our Milestones series, we take a look at a key breast cancer molecule and the development of the breast cancer drug Herceptin.

by Sarah Hazell | Analysis | 20 September 2013

20 September 2013

This entry is part 14 of 30 in the series Our milestones

Giving radiotherapy in fewer, larger treatments is at least as safe and effective at treating early breast cancer as the international standard dose. Giving radiotherapy in fewer, larger treatments is at least as safe and effective at treating early breast cancer as the international standard dose.

by Cancer Research UK | News | 19 September 2013

19 September 2013

Headlines

Following reports that women who stop taking the breast cancer drug tamoxifen could face their cancer returning, we look at the research behind the headlines. Following reports that women who stop taking the breast cancer drug tamoxifen could face their cancer returning, we look at the research behind the headlines.

by Henry Scowcroft | Analysis | 4 September 2013

4 September 2013

Cancer Research UK logo

In the wake of a huge study mapping cancer genetics, new research has linked a tiny bit of genetic material to the immune system and breast cancer. In the wake of a huge study mapping cancer genetics, new research has linked a tiny bit of genetic material to the immune system and breast cancer.

by Kat Arney | Analysis | 5 August 2013

5 August 2013

Cancer Research UK logo

Cancer news often gets more attention if a celebrity has been diagnosed, but does this help raise awareness or can the celebrity angle do more harm than good? Cancer news often gets more attention if a celebrity has been diagnosed, but does this help raise awareness or can the celebrity angle do more harm than good?

by Kat Arney | Analysis | 5 July 2013

5 July 2013